Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Smart Hospitals to Invest over $11 billion in Cloud Computing and Data Analytics, Says Frost & Sullivan

By 2025, 10 percent of hospitals across the globe will become or will have started implementations to become smart hospitals.

Read More »

More than 2,000 drugs now in cancer immunotherapy race

The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development.

Read More »

Lumicell Presents Phase 2 Clinical Data Showing LUM System Provided Complete and Immediate Detection of Residual Cancer in Tumor Cavity During Lumpectomy Surgery

Lumicell Inc. announced the presentation of clinical data from its ongoing Phase 2 breast cancer trial with the LUM System, which integrates the immuno- and cancer-targeted optical agent LUM015, the Lumicell handheld imaging device and decision software to detect cancer cells in real-time during surgery.

Read More »

Lumicell Expands Development Strategy and Pipeline Across Five Solid Tumor Cancers Supported by $28.7 Million Series C Financing

Lumicell Inc. provided an update on the company’s development strategy for its LUM system pipeline including plans to initiate its pivotal trial in breast cancer as well as expansion of its clinical studies in four other solid tumor cancers.

Read More »

Sage’s depression drug succeeds in study

Sage Therapeutics Inc.’s drug to treat patients with moderate to severe depression met the main goal in a mid-stage study.

Read More »

Intouch Solutions Advances Strategic Planning and Client Services Offerings with Leadership Promotions

Intouch Solutions, a leading marketing agency serving the pharmaceutical industry, announced several leadership promotions.

Read More »

Roche drug cocktail doubles chance of holding lung cancer at bay

Adding Roche’s immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labelled unprecedented.

Read More »

UnitedHealth to buy DaVita primary care unit

The largest U.S. health insurer UnitedHealth Group Inc will buy DaVita Inc’s primary and urgent care services for $4.9 billion in its second acquisition this year.

Read More »

U.S. healthcare spending growth slowed in 2016

Growth in healthcare spending in the United States slowed in 2016 following two years of expansion under the Affordable Care Act.

Read More »

Cambridge Biotech Obsidian Launches With $49.5M Investment From Google, Takeda, Vertex, Amgen and Others

Obsidian Therapeutics officially launched with the completion of a Series A financing worth $49.5 million. Obsidian is focusing on immuno-oncology, and includes regulated cytokine cassettes to be used with CAR-T products.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom